Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BYSurgical case reports

Malignant Perivascular Epithelioid Cell Tumor Originating from the Transverse Mesocolon.

  1. 1Department of Gastroenterological Surgery, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan.
  2. 2Department of Diagnostic Pathology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan.
  3. 3Department of Gastroenterological Surgery, Nippon Medical School, Tokyo, Japan.

Abstract

Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with melanocytic and smooth muscle differentiation. Primary mesenteric PEComas are exceptionally uncommon and usually cannot be diagnosed from imaging alone. We report a case of malignant PEComa arising from the transverse mesocolon. A 34-year-old woman was referred to our department after abdominal ultrasonography showed a large intra-abdominal mass. Contrast-enhanced CT revealed a 15-cm heterogeneous, hypervascular mesenteric tumor with internal necrosis and feeding vessels from the superior mesenteric artery. MRI showed no continuity with the uterus or ovaries. Because percutaneous biopsy was considered to carry a substantial risk of bleeding and dissemination, the tumor was resected for diagnosis and treatment. Laparotomy demonstrated a transverse-mesocolic tumor directly invading the transverse colon; transverse colectomy with en bloc tumor resection was performed. Histopathological evaluation showed pleomorphic epithelioid cells, marked nuclear atypia, coagulative necrosis, vascular invasion, and frequent mitoses. The tumor was positive for HMB-45, Melan-A, and smooth muscle actin and negative for TFE3, supporting malignant PEComa. The postoperative course was uneventful, and the patient remained free of recurrence 4 months after surgery. Malignant PEComa of the transverse mesocolon is extremely rare. This tumor should be considered among large, hypervascular mesenteric tumors, although imaging is not specific. Complete resection with negative margins is the principal treatment for localized disease. High-risk pathological features justify prolonged cross-sectional imaging surveillance and multidisciplinary, molecularly informed management if recurrence develops.

Related

  1. Imaging and Histopathologic Features of Incidentally Detected Hepatic Perivascular Epithelioid Cell Tumors: A Case Report.
    Pilwon Jeong, Jae Woon Kim, Joon Hyuk Choi
    Journal of the Korean Society of RadiologyPeer-reviewedCC BY-NCFull textPhysiologyEurope PMC
  2. Giant Cystic Lymphangioma of the Transverse Mesocolon in a 7-Year-Old Child: A Case Report.
    Mohamed Abdullahi Awale, Mariam Hassan Ali, Intisar Ahmed Abdi +4
    International medical case reports journalPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC
  3. Expression of phospho-S6 and its correlation with clinicopathological characteristics in retroperitoneal extravisceral perivascular epithelioid cell tumors
    Lei Liu, Wenjie Li, Shibo Liu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  4. Giant primary hydatid cyst of the sigmoid mesocolon: a surgical case report
    Unaiza Erum, Omer Bin Khalid Jamil, Muhammad Imran +4
    Annals of medicine and surgery (2012)Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. [Comment] Persistent descending mesocolon and its impact on the short-term outcomes of minimally invasive colorectal surgery: a systematic review and meta-analysis
    Wang Xiaojie
    结直肠肛门外科Peer-reviewedCC BY-NC-NDFull textOncologyDOAJ
BibTeX
@article{yokota2026malignant,
  title = {{Malignant Perivascular Epithelioid Cell Tumor Originating from the Transverse Mesocolon.}},
  author = {Ryo Yokota and Ryo Ohta and Kohki Takeda and Kumiko Sekiguchi and Takao Shimizu and Norio Motoda and Nobuhiko Taniai and Akihisa Matsuda},
  journal = {Surgical case reports},
  year = {2026},
  month = oct,
  doi = {10.70352/scrj.cr.26-0592},
  url = {https://europepmc.org/article/MED/42953579},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Malignant Perivascular Epithelioid Cell Tumor Originating from the Transverse Mesocolon.
AU  - Ryo Yokota
AU  - Ryo Ohta
AU  - Kohki Takeda
AU  - Kumiko Sekiguchi
AU  - Takao Shimizu
AU  - Norio Motoda
AU  - Nobuhiko Taniai
AU  - Akihisa Matsuda
PY  - 2026
DA  - 2026/10/28
JO  - Surgical case reports
DO  - 10.70352/scrj.cr.26-0592
UR  - https://europepmc.org/article/MED/42953579
AB  - Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal neoplasms with melanocytic and smooth muscle differentiation. Primary mesenteric PEComas are exceptionally uncommon and usually cannot be diagnosed from imaging alone. We report a case of malignant PEComa arising from the transverse mesocolon. A 34-year-old woman was referred to our department after abdominal ultrasonography showed a large intra-abdominal mass. Contrast-enhanced CT revealed a 15-cm heterogeneous, hypervascular mesenteric tumor with internal necrosis and feeding vessels from the superior mesenteric artery. MRI showed no continuity with the uterus or ovaries. Because percutaneous biopsy was considered to carry a substantial risk of bleeding and dissemination, the tumor was resected for diagnosis and treatment. Laparotomy demonstrated a transverse-mesocolic tumor directly invading the transverse colon; transverse colectomy with en bloc tumor resection was performed. Histopathological evaluation showed pleomorphic epithelioid cells, marked nuclear atypia, coagulative necrosis, vascular invasion, and frequent mitoses. The tumor was positive for HMB-45, Melan-A, and smooth muscle actin and negative for TFE3, supporting malignant PEComa. The postoperative course was uneventful, and the patient remained free of recurrence 4 months after surgery. Malignant PEComa of the transverse mesocolon is extremely rare. This tumor should be considered among large, hypervascular mesenteric tumors, although imaging is not specific. Complete resection with negative margins is the principal treatment for localized disease. High-risk pathological features justify prolonged cross-sectional imaging surveillance and multidisciplinary, molecularly informed management if recurrence develops.
SN  - 2198-7793
ER  -